Observational Study on Oropharyngeal Carcinoma
This study aims to better understand oropharyngeal carcinoma (OPC), a type of throat cancer, and its connection to the human papilloma virus (HPV). Researchers will collect blood samples from patients with OPC before they start treatment and at six different times afterward. The goal is to learn more about how this cancer develops and changes over time. You may be able to join if you are 18 or older and have been diagnosed with oropharyngeal carcinoma, or a cancer of unknown origin that is linked to HPV or thought to be from the oropharynx. This is an observational study, meaning no specific interventions or treatments are being tested.
- Study design
- This is an observational study with a planned enrollment of 1000 participants. It is not a treatment study, but rather focuses on collecting information.
- What's involved
- Participants will have blood collected prior to starting treatment and at six subsequent time points.
- Compensation
- Not stated in the trial record.
- Follow-up
- Blood samples will be collected for up to 36 months after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Chris Holsinger, MD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Sample collectionprior to start of treatment
30-50cc of blood
- Sample collectionup to 36 months post-op
30-50cc of blood